Richter Grace M, Coleman Anne L
UCLA Stein Eye Institute, Department of Ophthalmology, University of California, Los Angeles, CA, USA; USC Eye Institute, Department of Ophthalmology, Keck School of Medicine of University of Southern California, Los Angeles, CA, USA.
UCLA Stein Eye Institute, Department of Ophthalmology, University of California, Los Angeles, CA, USA.
Clin Ophthalmol. 2016 Jan 28;10:189-206. doi: 10.2147/OPTH.S80490. eCollection 2016.
Minimally invasive glaucoma surgery aims to provide a medication-sparing, conjunctival-sparing, ab interno approach to intraocular pressure reduction for patients with mild-to-moderate glaucoma that is safer than traditional incisional glaucoma surgery. The current approaches include: increasing trabecular outflow (Trabectome, iStent, Hydrus stent, gonioscopy-assisted transluminal trabeculotomy, excimer laser trabeculotomy); suprachoroidal shunts (Cypass micro-stent); reducing aqueous production (endocyclophotocoagulation); and subconjunctival filtration (XEN gel stent). The data on each surgical procedure for each of these approaches are reviewed in this article, patient selection pearls learned to date are discussed, and expectations for the future are examined.
微创青光眼手术旨在为轻至中度青光眼患者提供一种减少用药、保留结膜、经内路降低眼压的方法，该方法比传统的切开性青光眼手术更安全。目前的方法包括：增加小梁网房水流出量（ Trabectome手术、iStent植入术、Hydrus支架植入术、前房角镜辅助的经腔小梁切开术、准分子激光小梁切开术）；脉络膜上腔分流术（Cypass微支架植入术）；减少房水生成（眼内睫状体光凝术）；以及结膜下滤过术（XEN凝胶支架植入术）。本文回顾了这些方法中每种手术方法的数据，讨论了目前所掌握的患者选择要点，并探讨了对未来的期望。
